Skip to main content
Thermo Fisher Scientific Inc. (TMO)
NYSE: TMO · Real-Time Price · USD
422.27
-1.28 (-0.30%)
May 5, 2025, 4:00 PM EDT - Market closed

Thermo Fisher Revenue by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Laboratory Products
23.07B 23.16B 22.94B 22.93B 23.00B 23.04B 23.27B 23.13B
Laboratory Products Growth
0.32% 0.50% -1.41% -0.86% 0.74% 2.35% 12.09% 23.93%
Life Sciences Solutions
9.69B 9.63B 9.50B 9.54B 9.65B 9.98B 10.55B 11.08B
Life Sciences Solutions Growth
0.38% -3.47% -10.02% -13.90% -18.99% -26.27% -27.89% -28.00%
Analytical Instruments
7.49B 7.46B 7.31B 7.26B 7.23B 7.26B 7.10B 6.97B
Analytical Instruments Growth
3.69% 2.75% 2.96% 4.15% 5.83% 9.65% 9.78% 10.20%
Speciality Diagnostics
4.55B 4.51B 4.46B 4.41B 4.41B 4.41B 4.42B 4.40B
Speciality Diagnostics Growth
3.29% 2.43% 1.02% 0.39% 0.39% -7.52% -13.35% -18.45%
Eliminations
-1.91B -1.88B -1.84B -1.80B -1.79B -1.83B -1.92B -2.05B

Operating Income by Segment
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Life Sciences Solutions
3.50B 3.50B 3.45B 3.47B 3.42B 3.42B 3.57B 3.73B
Life Sciences Solutions Growth
2.10% 2.40% -3.37% -6.97% -19.28% -38.73% -45.50% -49.04%
Laboratory Products
3.08B 3.09B 3.07B 3.23B 3.31B 3.36B 3.39B 3.18B
Laboratory Products Growth
-7.01% -7.98% -9.56% 1.64% 8.67% 16.92% 34.52% 45.91%
Analytical Instruments
1.96B 1.96B 1.88B 1.89B 1.89B 1.91B 1.80B 1.72B
Analytical Instruments Growth
3.60% 2.52% 4.45% 10.44% 15.98% 26.61% 27.27% 32.95%
Speciality Diagnostics
1.17B 1.16B 1.15B 1.14B 1.14B 1.12B 1.07B 1.01B
Speciality Diagnostics Growth
2.72% 3.11% 7.68% 13.43% 19.66% 9.77% -4.04% -16.46%

Operating Expense Breakdown
Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017
Selling, General, and Administrative
6.99B 7.00B 6.83B 6.67B 6.65B 6.57B 6.73B 6.90B
Selling, General, and Administrative Growth
5.09% 6.61% 1.43% -3.33% -4.47% -7.83% -7.12% -4.63%
Amortization of Intangibles
1.83B 1.95B 2.08B 2.21B 2.28B 2.34B 2.37B 2.38B
Amortization of Intangibles Growth
-19.84% -16.51% -12.25% -6.98% -4.56% -2.38% 4.32% 13.30%
Research and Development
1.40B 1.39B 1.34B 1.32B 1.32B 1.34B 1.40B 1.43B
Research and Development Growth
5.98% 3.96% -4.14% -8.16% -9.02% -9.11% -4.82% -2.65%
Restructuring and Other
448.00M 379.00M 231.00M 270.00M 376.00M 459.00M 434.00M 383.00M
Restructuring and Other Growth
19.15% -17.43% -46.77% -29.50% 67.86% 302.63% 313.33% 325.56%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.